ACCORD HEALTHCARE LIMITED
Location
Founded
2004-04-13
Risk Signals
337 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Medicinal Chemicals and Botanical Products, Pharmaceutical Preparations, Drugs, Drug Proprietaries, and Druggists' Sundries), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about ACCORD HEALTHCARE LIMITED
Live alerts from global media, monitored by Business Radar
2022-01-24 (canadanewsmedia.ca)
Dividend hikes punctuate successful quarter for financial services firms - Investment Executive
In the quarters ended between Aug. 31 and Oct. 31, 2021, 26 of the companies reported higher year-over-year earnings; one firm, RF Capital Group Inc., posted positive net income compared to a loss a year earlier; 12 companies reported lower
Read more2019-01-30 (chroniclelive.co.uk)
Pharma firm Accord trebles in size a year after creating new jobs in Newcastle factory
Accord Heathcare already has 200 staff at its Fawdon site and is on track to employ 500 by 2020
Read more(fiercepharma.com)
Accord wins £50M joint investment from UK to bolster local production of cancer, immunology drugs
As the U.K. works to pump fresh cash into the local biopharma scene, London’s Accord Healthcare is capitalizing on the government’s renewed willingness to chip in. | Flush with a 50 million pound sterling ($65 million) joint investment deal from the U.K., Accord—one of Europe's top makers of generic chemotherapies—is embarking on an expansion of its Fawdon drug manufacturing facility in Newcastle upon Tyne, England.
Read more(finanznachrichten.de)
Accord Healthcare unlocks £50m government fund to boost medicines manufacturing in the North-East
Accord welcomes a joint £50 million deal with the government to invest in the manufacture and production of its high-quality medicines at its plant in Fawdon, Newcastle upon Tyne.The investment
Read more